OCM
AMGN icon

Objective Capital Management’s Amgen AMGN Stock Holding History

Objective Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,098
Closed -$286K – 80
2024
Q4 		$286K Sell
1,098
-277
-20% -$82.2K 0.19% 105
2024
Q3 		$443K Buy
+1,375
New +$450K 0.26% 85
2024
Q1 		$241K Buy
848
+9
+1% +$2.63K 0.16% 118
2023
Q4 		$242K Buy
839
+1
+0.1% +$272 0.18% 102
2023
Q3 		$225K Buy
+838
New +$209K 0.2% 91
2023
Q2 		– Sell
-871
Closed -$211K – 99
2023
Q1 		$211K Buy
+871
New +$214K 0.19% 91

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Objective Capital Management's AMGN Position: Q1 2025 in Review

Objective Capital Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,098 shares — an estimated $286K sold.

Objective Capital Management first reported a position in AMGN in Q1 2023 and held it in 6 quarters. The position peaked at $443K in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Objective Capital Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Objective Capital Management sold 1,098 Amgen shares in Q1 2025, an estimated $286K.
  • Objective Capital Management first reported a position in Amgen in Q1 2023 and held it in 6 quarters.
  • Objective Capital Management's Amgen position peaked at $443K in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Objective Capital Management's 13F filing for Q1 2025, filed 7 May 2025.